Atlas Trials

Gene Therapy(FT-003) for Wet AMD

Clinical trial NCT06492863 · RECRUITING

Trial details

NCT number
NCT06492863
Sponsor
Frontera Therapeutics
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neovascular Age-related Macular Degeneration
Start date
2023-08-15
Primary completion
2024-10-15
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.